Standout Papers
Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of Christopher Russell being referenced
Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant disease
2021
Recommendations for management of patients with neuroendocrine liver metastases
2014 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Christopher Russell | 187 | 194 | 115 | 418 | 347 | 28 | 709 | |
| Jennifer R. Eads | 175 | 148 | 91 | 585 | 321 | 47 | 778 | |
| A Autret | 334 | 264 | 68 | 465 | 283 | 43 | 757 | |
| D.G. Haller | 285 | 176 | 91 | 531 | 170 | 28 | 791 | |
| Mi Kyung Bae | 462 | 201 | 139 | 288 | 136 | 29 | 805 | |
| İ. Çeli̇k | 73 | 59 | 191 | 320 | 222 | 29 | 686 | |
| Ulrich Stölzel | 173 | 113 | 218 | 330 | 153 | 30 | 769 | |
| Marta Llanos | 103 | 68 | 84 | 437 | 260 | 44 | 745 | |
| P. Ruszniewski | 65 | 334 | 179 | 359 | 454 | 51 | 841 | |
| Nathalie Théou–Anton | 312 | 78 | 125 | 358 | 132 | 28 | 649 | |
| Laura Tang | 90 | 152 | 41 | 481 | 507 | 15 | 768 |
All Works
Login with ORCID to disown or claim papers
Loading papers...